CD8A and cancer: CDSI‐high was linked to increased angiogenesis, whereas CDSI‐low was associated with enhanced activation of cell cycle, DNA damage response, and CD8 T effector pathways (Figure 4A), as well as higher cancer stemness levels, as measured by the mRNAsi score (Figure 4B) [26].